V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003408 | 330001762 | 1.65 | null | null | null | 2016-12-03 | CVP R | null | null | 330012801 | CVP R |
| 330003409 | 330001762 | 1.7 | 80.6 | Neo-adjuvant (N) | 2017-01-11 | 2017-01-12 | CARBOPLATIN + FLUOROURACIL | 2 | N | 330012801 | CARBO + FLUOROURACIL |
| 330003410 | 330001763 | 1.76 | 88 | Neo-adjuvant (N) | 2014-08-18 | 2014-08-24 | Dox + HD Mtx (post PAM) | N | N | 330012805 | DOXORUBICIN + HD MTX |
| 330003411 | 330001764 | 1.75 | 53 | Curative (C) | 2016-11-20 | 2016-11-21 | EW EuroEwing 99 : VIDE | 02 | N | 330012806 | EURO-EWING |
| 330003412 | 330001765 | 1.72 | null | Adjuvant (A) | 2015-03-30 | 2015-04-02 | PAM | N | null | 330012807 | MAP |
| 330003413 | 330001766 | 1.72 | 61 | Adjuvant (A) | 2016-04-18 | 2016-04-18 | PAM x 2 pre-surgery (cycles 1&2) | N | N | 330012809 | MAP |
| 330003414 | 330006945 | 1.77 | 84 | Curative (C) | 2016-06-01 | 2016-06-07 | DA | N | N | 330012810 | DA |
| 330003415 | 330006945 | null | 65.4 | Adjuvant (A) | 2016-11-25 | 2016-11-25 | EURAMOS TRIAL | 2 | N | 330012810 | EURAMOS TRIAL |
| 330003416 | 330001767 | 1.8 | 101.85 | Curative (C) | 2015-07-02 | 2015-07-04 | DA 3 + 10 | N | N | 330012816 | DA |
| 330003417 | 330001767 | 1.62 | 65.4 | Curative (C) | 2016-03-15 | 2016-03-29 | EW EuroEwing 99 : VIDE | N | N | 330012816 | EURO-EWING |
| 330003418 | 330001768 | 1.77 | 81.1 | null | 2017-11-23 | 2017-12-08 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012818 | CARBO + FLUOROURACIL |
| 330003419 | 330001768 | 1.88 | 77 | Curative (C) | 2016-12-26 | 2016-12-26 | Dox + HD Mtx (post PAM) | 02 | null | 330012818 | DOXORUBICIN + HD MTX |
| 330003420 | 330001769 | 1.82 | null | Neo-adjuvant (N) | null | 2013-06-25 | PAM | N | N | 330012823 | MAP |
| 330003421 | 330006948 | 1.62 | 83.9 | null | 2014-02-15 | 2014-02-15 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330012826 | CARBO + FLUOROURACIL |
| 330003422 | 330006948 | 0 | null | Neo-adjuvant (N) | 2014-04-14 | 2014-04-19 | Dox + HD Mtx (post PAM) | N | N | 330012826 | DOXORUBICIN + HD MTX |
| 330003423 | 330006948 | null | 76.7 | Adjuvant (A) | 2014-12-04 | 2014-12-25 | CETUXIMAB + RT | N | N | 330012826 | CETUXIMAB + RT |
| 330003424 | 330006948 | 1.66 | 92 | null | null | 2016-05-04 | GemCarbo Days 1+8 | null | null | 330012826 | GEMCARBO |
| 330003426 | 330001771 | 1.73 | 78 | Not known (9) | 2016-08-06 | 2016-08-08 | Cetuximab + Radiotherapy Load | Y | N | 330012835 | CETUXIMAB + RT |
| 330003427 | 330006949 | 1.79 | 75.5 | Curative (C) | 2015-09-10 | 2015-09-13 | CETUXIMAB | 2 | N | 330012841 | CETUXIMAB |
| 330003428 | 330006949 | 1.8 | 21.1 | Neo-adjuvant (N) | 2013-03-03 | 2013-03-16 | OST Euramos 1 Closed Trial - AP | 2 | N | 330012841 | MAP |
| 330003429 | 330011308 | 1.74 | 84.3 | Curative (C) | null | 2017-08-27 | DA 3 + 10 | null | null | 330012846 | DA |
| 330003430 | 330011308 | 1.55 | 70.1 | Neo-adjuvant (N) | 2017-12-10 | 2017-12-29 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 330012846 | CISPLATIN + GEMCITABINE |
| 330003431 | 330001772 | 1.56 | 62.6 | Curative (C) | 2016-07-09 | 2016-07-17 | MAP | N | N | 330012848 | MAP |
| 330003432 | 330001772 | 1.65 | 54.9 | Neo-adjuvant (N) | null | 2016-04-03 | Cisplatin + Etoposide (3 day) | N | N | 330012848 | CISPLATIN + ETOPOSIDE |
| 330003433 | 330001772 | 1.1 | 77 | Palliative (P) | 2016-04-06 | 2016-04-06 | CISPLATIN + ETOPOSIDE | N | N | 330012848 | CISPLATIN + ETOPOSIDE |
| 330003434 | 330001772 | 1.68 | 79.2 | Curative (C) | 2014-08-05 | 2014-08-17 | CVP R | null | N | 330012848 | CVP R |
| 330003435 | 330001772 | 0 | 75.2 | null | null | 2015-01-15 | CVP R | null | null | 330012848 | CVP R |
| 330003436 | 330001772 | 1.7 | 97.5 | Palliative (P) | 2016-07-05 | 2016-07-18 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012848 | CARBO + FLUOROURACIL |
| 330003437 | 330001773 | null | 96.7 | Neo-adjuvant (N) | 2016-09-16 | 2016-09-26 | OST Euramos 1 Closed Trial - AP | null | N | 330012860 | MAP |
| 330003438 | 330001774 | 1.78 | 79.6 | Adjuvant (A) | 2014-01-04 | 2014-01-04 | Dox + HD Mtx (post PAM) | Y | N | 330012861 | DOXORUBICIN + HD MTX |
| 330003439 | 330001775 | 1.52 | 37.9 | Neo-adjuvant (N) | 2015-11-02 | 2015-11-18 | CARBOPLATIN + GEMCITABINE | N | N | 330012862 | GEMCARBO |
| 330003440 | 330001775 | 1.84 | 78 | Neo-adjuvant (N) | 2013-09-24 | 2013-09-24 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330012862 | EURO-EWING |
| 330003441 | 330001775 | null | null | Neo-adjuvant (N) | 2015-06-11 | 2015-06-18 | EP 1 2 or 3 day | 02 | N | 330012862 | CISPLATIN + ETOPOSIDE |
| 330003442 | 330011310 | 1.7 | 136.5 | Neo-adjuvant (N) | 2013-09-21 | 2013-09-30 | Dox + HD Mtx (post PAM) | N | N | 330012868 | DOXORUBICIN + HD MTX |
| 330003443 | 330011310 | 1.78 | 77.2 | Disease modification (D) | 2017-04-24 | 2017-04-24 | Cyclophosphamide + Dex + Rituximab | N | N | 330012868 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003444 | 330011310 | 1.18 | 88.4 | Curative (C) | 2016-12-12 | 2017-01-09 | CETUXIMAB | N | Y | 330012868 | CETUXIMAB |
| 330003445 | 330011310 | 1.77 | 62.8 | Disease modification (D) | 2013-10-19 | 2013-11-01 | Cyclophosphamide + Dex + Rituximab | N | N | 330012868 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003446 | 330001776 | null | 78.9 | Neo-adjuvant (N) | 2015-03-14 | 2015-03-14 | CARBO + FLUOROURACIL | N | N | 330012880 | CARBO + FLUOROURACIL |
| 330003447 | 330001777 | 1.76 | 70.9 | Palliative (P) | 2017-01-26 | 2017-02-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 330012881 | CISPLATIN + GEMCITABINE |
| 330003448 | 330006952 | 0 | 51.3 | Palliative (P) | 2016-10-31 | 2016-10-31 | CARBO + FLUOROURACIL | 02 | N | 330012882 | CARBO + FLUOROURACIL |
| 330003449 | 330006952 | null | null | Curative (C) | 2014-08-24 | 2014-08-26 | Cetuximab + Radiotherapy Load | N | Y | 330012882 | CETUXIMAB + RT |
| 330003450 | 330001778 | 1.71 | 58.7 | Curative (C) | 2014-08-23 | 2014-08-30 | EURO-EWING | Y | N | 330012889 | EURO-EWING |
| 330003451 | 330001778 | 1.71 | 50 | Neo-adjuvant (N) | 2015-05-05 | 2015-05-08 | Dox + HD Mtx (post PAM) | 2 | N | 330012889 | DOXORUBICIN + HD MTX |
| 330003452 | 330001778 | 1.62 | 61 | Palliative (P) | 2017-06-07 | 2017-07-09 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330012889 | CISPLATIN + GEMCITABINE |
| 330003453 | 330001778 | 1.69 | 85 | Curative (C) | 2015-08-26 | 2015-09-10 | Cetuximab + Radiotherapy Load | N | Y | 330012889 | CETUXIMAB + RT |
| 330003454 | 330001779 | 1.58 | 22.7 | Palliative (P) | 2016-08-18 | 2016-08-29 | GemCarbo Days 1+8 | N | Y | 330012899 | GEMCARBO |
| 330003455 | 330006954 | 1.84 | 98 | Palliative (P) | 2018-05-31 | 2018-06-21 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 330012900 | CISPLATIN + GEMCITABINE |
| 330003456 | 330006954 | 1.71 | 79.6 | Adjuvant (A) | 2015-10-24 | 2015-10-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330012900 | CISPLATIN + GEMCITABINE |
| 330003457 | 330006954 | 1.75 | null | Curative (C) | 2014-07-19 | 2014-07-22 | DA 3 + 10 | N | N | 330012900 | DA |
| 330003458 | 330006954 | 1.86 | null | Neo-adjuvant (N) | 2015-05-29 | 2015-05-29 | Carbo F | N | N | 330012900 | CARBO + FLUOROURACIL |